CIK 0001175151
- Non-accelerated filer
- Smaller reporting company
Cytosorbents Corp
Sign in to watch- Ticker
- CTSO
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 980373793
- Phone
- +1 973-329-8885
- Business address
- 305 COLLEGE ROAD EAST, PRINCETON, NJ, 08540
- Former names
- MedaSorb Technologies CORP, GILDER ENTERPRISES INC
- 4 Open-market sale 10% owner sold 124,281 shares at an average $3.44 ($427,662)
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Chief Financial Officer bought 2,125 shares at $7.05 ($14,981)
- 4 Open-market sale Chief Operating Officer sold 4,000 shares at $7.50 ($30,000)
- 4 Option exercise President and CEO acquired 3,467 shares (option exercise)
- 4 Open-market sale Director sold 6,774 shares at $6.22 ($42,122)
- 4 Open-market sale Director sold 10,000 shares at $6.39 ($63,913)
- 4 Open-market sale Director sold 10,000 shares at $6.26 ($62,591)
- 4 Open-market sale Director sold 10,000 shares at $6.44 ($64,361)
- 4 Open-market sale Director sold 10,000 shares at $6.64 ($66,373)
- 4 Open-market sale Director sold 10,000 shares at $7.26 ($72,600)
- 4 Open-market sale Director sold 10,000 shares at $7.26 ($72,585)
- 4 Open-market sale Director sold 10,000 shares at $6.39 ($63,937)
- 4 Open-market sale Director sold 10,000 shares at $7.26 ($72,631)
- 4 Open-market sale Director sold 10,000 shares at $6.26 ($62,593)
- 4 Open-market sale Director sold 10,000 shares at $6.48 ($64,827)
- 4 Open-market sale Director sold 10,000 shares at $6.34 ($63,397)
- 4 Open-market sale Director sold 10,000 shares at $6.28 ($62,777)
- 4 Open-market sale Director sold 10,000 shares at $6.33 ($63,303)
- 4 Derivatives Options or other derivatives
Page 12 of 20 · 395 filings